Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Bruxelles  >  Bone Therapeutics SA    BOTHE   BE0974280126

BONE THERAPEUTICS SA

(BOTHE)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
07/07/2020 07/08/2020 07/09/2020 07/10/2020 07/13/2020 Date
2.41(c) 2.41(c) 2.32(c) 2.31(c) 2.34 Last
11 985 4 567 37 354 25 050 15 919 Volume
+0.42% 0.00% -3.73% -0.43% +1.30% Change
More quotes
Financials
Sales 2020 5,25 M 5,95 M 5,95 M
Net income 2020 - - -
Net Debt 2020 - - -
P/E ratio 2020 -
Yield 2020 -
Sales 2021 3,93 M 4,46 M 4,46 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 26,9 M 30,5 M 30,5 M
Capi. / Sales 2020 5,13x
Capi. / Sales 2021 6,85x
Nbr of Employees 58
Free-Float 89,3%
More Financials
Company
Bone Therapeutics SA is a leading biotech company focused on the development of innovative products to address high unmet needs in orthopaedics and bone diseases. Bone Therapeutics' core technology is based on its allogeneic cell therapy platform (ALLOB) which uses a unique, proprietary approach to bone regeneration, which turns undifferentiated stem cells from healthy donors into bone-forming cells. These cells... 
More about the company
Latest news on BONE THERAPEUTICS SA
06/11BONE THERAPEUTICS : announces Annual General Meeting results and confirms outloo..
AQ
05/30BONE THERAPEUTICS SA : Threshold crossings
CO
05/29BONE THERAPEUTICS SA : Transparency notification received from S.R.I.W. SA and S..
AQ
05/29BONE THERAPEUTICS SA : Threshold crossings
CO
05/18BONE THERAPEUTICS : 5/18/20 - Bone Therapeutics treats first patients in pivotal..
PU
05/18BONE THERAPEUTICS : treats first patients in pivotal JTA-004 phase III knee oste..
AQ
05/11BONE THERAPEUTICS : to host Annual Ordinary General Meeting on 10 June 2020
AQ
05/07BONE THERAPEUTICS : raises additional EUR 4.0 million, with total of EUR 15.0 mi..
AQ
05/06BONE THERAPEUTICS : Provides First Quarter 2020 Business Update
AQ
04/29BONE THERAPEUTICS : secures EUR 11.0 million financing
AQ
04/03BONE THERAPEUTICS SA : Monthly statement on outstanding equity shares and voting..
CO
04/03BONE THERAPEUTICS SA : Threshold crossings
CO
03/26BONE THERAPEUTICS : appoints Stefanos Theoharis as Chief Business Officer
AQ
03/26BONE THERAPEUTICS SA : Nomination
CO
03/24BONE THERAPEUTICS : TCR therapy - an attractive alternative to CAR T
AQ
More news
News in other languages on BONE THERAPEUTICS SA
06/11BONE THERAPEUTICS : announces Annual General Meeting results and confirms outloo..
05/29BONE THERAPEUTICS SA : Transparency notification received from S.R.I.W. SA and S..
05/18Les valeurs à suivre aujourd'hui à la Bourse de Paris Lundi 18 mai 2020
05/18BONE THERAPEUTICS : traitement des premiers patients suite à la reprise des acti..
05/18BONE THERAPEUTICS : 5/18/20 - Bone Therapeutics treats first patients in pivotal..
More news
Chart BONE THERAPEUTICS SA
Duration : Period :
Bone Therapeutics SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BONE THERAPEUTICS SA
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 5,00 €
Last Close Price 2,31 €
Spread / Highest target 160%
Spread / Average Target 116%
Spread / Lowest Target 73,2%
Managers
NameTitle
Miguel Forte Chief Executive Officer
Baron Jean Stéphenne Chairman
Jean-Luc Vandebroek Chief Financial Officer & Executive Director
Olivier Godeaux Chief Medical Officer
Benoit Moreaux Chief Scientific & Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
BONE THERAPEUTICS SA-36.63%30
MERCK KGAA4.56%54 181
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD66.07%15 725
KYOWA KIRIN CO., LTD.4.16%13 480
BETTA PHARMACEUTICALS CO., LTD.137.75%8 948
JAZZ PHARMACEUTICALS PLC-28.59%5 900